Davies Mark G, Hart Joseph P
Department of Cardiovascular Outcomes, Center for Quality, Effectiveness, and Outcomes in Cardiovascular Diseases, Houston, TX, United States.
Division of Vascular and Endovascular Surgery, Medical College of Wisconsin, Milwaukee, WI, United States.
Front Surg. 2024 Feb 19;11:1302568. doi: 10.3389/fsurg.2024.1302568. eCollection 2024.
Approximately 3% of all patients presenting with Thoracic Outlet Syndrome have a venous etiology (vTOS), which is considered "effort thrombosis". These patients will present with symptomatic deep venous thrombosis or focal subclavian vein (SCV) stenosis. Endovascular management of vTOS occurs in several phases: diagnostic, preoperative therapeutic intervention before decompression, postoperative interventions after decompression, and delayed interventions in the follow-up after decompression. In the diagnostic phase, dynamic SCV venography can establish functional vTOS. Approximately 4,000 patients have been treated for vTOS and reported in the literature since 1970. Declotting of the SCV was followed by surgical decompression in 53% of patients, while in the remainder, surgical decompression alone (18%), endovascular intervention alone (15%), or conservative therapy with anticoagulation (15%) was performed. The initial intervention was predominantly catheter-directed thrombolysis, with <10% of cases undergoing concomitant balloon angioplasty. 93% of cases were successful. In the postoperative phase, balloon angioplasty was performed to correct residual intrinsic SCV disease after vTOS decompression in under 15% of cases. Stents were rarely deployed. Symptom relief was reported as 94 ± 12% (mean ± SD) and 90 ± 23%, respectively for declotting with decompression and declotting alone. In the delayed phase, balloon angioplasty was performed in under 15% of cases to re-establish patency.
所有出现胸廓出口综合征的患者中,约3%有静脉病因(静脉性胸廓出口综合征,vTOS),这被认为是“用力性血栓形成”。这些患者会出现有症状的深静脉血栓形成或局灶性锁骨下静脉(SCV)狭窄。vTOS的血管内治疗分几个阶段:诊断阶段、减压术前的治疗性干预、减压术后的干预以及减压后随访中的延迟干预。在诊断阶段,动态SCV静脉造影可确诊功能性vTOS。自1970年以来,约4000例vTOS患者接受了治疗并在文献中有所报道。53%的患者在SCV血栓清除后进行了手术减压,其余患者则单独进行了手术减压(18%)、单独进行了血管内干预(15%)或采用抗凝进行保守治疗(15%)。初始干预主要是导管直接溶栓,不到10%的病例同时进行了球囊血管成形术。93%的病例获得成功。在术后阶段,不到15%的病例在vTOS减压后进行了球囊血管成形术以纠正残留的SCV固有病变。很少置入支架。血栓清除并减压和单纯血栓清除的症状缓解率分别报告为94±12%(均值±标准差)和90±23%。在延迟阶段,不到15%的病例进行了球囊血管成形术以重新建立通畅。